An oncology cell therapy company developing next-generation CAR-T therapeutics for solid tumors and hematologic malignancies.
Its proprietary logic-gating technology is designed to improve the targeting of cancer cells.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$90M
Total Amount Raised$90M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$90M
Latest Funding Amount$90M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 28, 2026
Series A
$90.00M
―
Similar Companies
A snapshot of private companies similar to Link Cell Therapies, helping you discover and navigate related company profiles.